{"result":[{"lastName":"Warnke","clinicalFocus":[{"focus":"Anatomic/Clinical Pathology"},{"focus":"Pathology and Laboratory Medicine"}],"appointments":[{"appointment":"Emeritus (Active) Professor,Pathology"},{"appointment":"Emeritus Faculty, Acad Council,Pathology"},{"appointment":"Member,Stanford Cancer Institute"}],"primaryAppointment":"Emeritus (Active) Professor,Pathology","imageUrl":"http://stanfordhospital.org/profiles/viewImage?facultyId=3786&type=small&showNoImage","displayName":"Roger Warnke","firstName":"Roger","href":"http://stanfordhospital.org/profiles/Roger_Warnke","researchInterest":"The research in my laboratory involves the application of monoclonal and polyclonal antibodies and a variety of immunohistochemical methods to study human B-cell, T-cell, accessory cell and related neoplasms."},{"lastName":"Arber","clinicalFocus":[{"focus":"Anatomic/Clinical Pathology"},{"focus":"Hematopathology"},{"focus":"Pathology"}],"appointments":[{"appointment":"Professor - Med Center Line,Pathology"}],"primaryAppointment":"Professor - Med Center Line,Pathology","imageUrl":"http://stanfordhospital.org/profiles/viewImage?facultyId=3925&type=small&showNoImage","displayName":"Daniel A. Arber, M.D.","firstName":"Daniel","href":"http://stanfordhospital.org/profiles/Daniel_Arber","researchInterest":"I study molecular genetic and immunophenotypic changes in human hematopoietic neoplasms. These include acute and chronic leukemias, lymphoma, and splenic tumors."},{"lastName":"Alizadeh","clinicalFocus":[{"focus":"Oncology"},{"focus":"Lymphoma"},{"focus":"B-Cell Chronic Lymphocytic Leukemia"},{"focus":"Waldenstrom Macroglobulinemia"},{"focus":"Burkitt Lymphoma"},{"focus":"Follicular Lymphoma"},{"focus":"Diffuse Large-Cell Lymphomas"},{"focus":"Leukemia, Hairy Cell"},{"focus":"Lymphoma, B-Cell, Marginal Zone"},{"focus":"Hodgkin Disease"}],"appointments":[{"appointment":"Assistant Professor,Medicine - Oncology"},{"appointment":"Member,Stanford Cancer Institute"},{"appointment":"Member,Child Health Research Institute"},{"appointment":"Member,Bio-X"}],"primaryAppointment":"Assistant Professor,Medicine - Oncology","imageUrl":"http://stanfordhospital.org/profiles/viewImage?facultyId=9558&type=small&showNoImage","displayName":"Ash A. Alizadeh, MD/PhD","firstName":"Arash","href":"http://stanfordhospital.org/profiles/Arash_Alizadeh","researchInterest":"My research is focused on attaining a better understanding of the initiation, maintenance, and progression of lymphoid tumors, and their response to immunochemotherapy toward improving current treatment strategies.  \r\n\r\nIn this effort, I employ tools from functional genomics, computational biology, molecular genetics, and mouse models.  I hope to apply this knowledge towards the design of clinical trials in the treatment of patients with lymphoma, leukemia, and myeloma."},{"lastName":"Majeti","clinicalFocus":[{"focus":"Hematology"}],"appointments":[{"appointment":"Assistant Professor,Medicine - Hematology"},{"appointment":"Member,Bio-X"}],"primaryAppointment":"Assistant Professor,Medicine - Hematology","imageUrl":"http://stanfordhospital.org/profiles/viewImage?facultyId=8250&type=small&showNoImage","displayName":"Ravindra Majeti","firstName":"Ravindra","href":"http://stanfordhospital.org/profiles/Ravindra_Majeti","researchInterest":"Ravindra Majeti focuses on the molecular characterization and therapeutic targeting of leukemia stem cells in human hematologic disorders, particularly acute myeloid leukemia (AML LSC). A major focus is the identification of cell surface molecules preferentially expressed on LSC and the development of therapeutic monoclonal antibodies targeting these proteins. Toward this goal, together with Irv Weissman, the lab is actively developing an anti-CD47 antibody for clinical trials in human AML."},{"lastName":"Volkmer","clinicalFocus":[],"appointments":[{"appointment":"Instructor,Stem Cell - Stem Cell Biology and Regenerative Medicine Institute"}],"primaryAppointment":"Instructor,Stem Cell - Stem Cell Biology and Regenerative Medicine Institute","imageUrl":"http://stanfordhospital.org/profiles/viewImage?facultyId=9789&type=small&showNoImage","displayName":"Jens-Peter Volkmer","firstName":"Jens-Peter","href":"http://med.stanford.edu/profiles/stanfordhospital/researcher/Jens-Peter_Volkmer","researchInterest":""},{"lastName":"Volkmer","clinicalFocus":[],"appointments":[{"appointment":"Postdoctoral Research fellow, Stem Cell"}],"primaryAppointment":"Postdoctoral Research fellow, Stem Cell","imageUrl":"http://stanfordhospital.org/profiles/viewImage?facultyId=20943&type=small&showNoImage","displayName":"Anne Kathrin Volkmer","firstName":"Anne","href":"http://med.stanford.edu/profiles/postdocs/researcher/Anne_Volkmer","researchInterest":""},{"lastName":"Reddy","clinicalFocus":[{"focus":"lymphoma/melanoma/cutaneouslymphoma"},{"focus":"Medical Oncology"}],"appointments":[{"appointment":"Clinical Instructor,Medicine - Oncology"}],"primaryAppointment":"Clinical Instructor,Medicine - Oncology","imageUrl":"http://stanfordhospital.org/profiles/viewImage?facultyId=7405&type=small&showNoImage","displayName":"Sunil Reddy","firstName":"Sunil","href":"http://stanfordhospital.org/profiles/Sunil_Reddy","researchInterest":""},{"lastName":"George","clinicalFocus":[],"appointments":[{"appointment":"Member,Stanford Cancer Institute"}],"primaryAppointment":"Member,Stanford Cancer Institute","imageUrl":"http://stanfordhospital.org/profiles/viewImage?facultyId=3926&type=small&showNoImage","displayName":"Tracy I. George","firstName":"Tracy","href":"http://med.stanford.edu/profiles/stanfordhospital/researcher/Tracy_George","researchInterest":"My interest in translational hematopathology includes systemic mastocytosis and other myeloproliferative neoplasms, laboratory hematology, post-transplant and immunodeficiency-related lymphoproliferative disorders, and reactive lymphadenopathies. I am the pathologist on two clinical trials in treating aggressive types of systemic mastocytosis with an alternative small molecule inhibitor. I chair CAP's Hematology & Clinical Microscopy Resource Committee."},{"lastName":"Weissman","clinicalFocus":[],"appointments":[{"appointment":"Professor,Pathology - Stem Cell Institute"},{"appointment":"Member,Bio-X"},{"appointment":"Member,Stanford Cancer Institute"},{"appointment":"Professor,Developmental Biology"},{"appointment":"Professor (By courtesy),Biology (School of Humanities and Sciences)"}],"primaryAppointment":"Professor,Pathology - Stem Cell Institute","imageUrl":"http://stanfordhospital.org/profiles/viewImage?facultyId=4605&type=small&showNoImage","displayName":"Irving Weissman","firstName":"Irving","href":"http://med.stanford.edu/profiles/stanfordhospital/researcher/Irving_Weissman","researchInterest":"Stem cell and cancer stem cell biology; development of T and B lymphocytes; cell-surface receptors for oncornaviruses in leukemia. Hematopoietic stem cells; Lymphocyte homing, lymphoma invasiveness and metastasis."},{"lastName":"Mendez","clinicalFocus":[{"focus":"General Pediatrics"}],"appointments":[{"appointment":"Clinical Instructor,Pediatrics - Neonatal and Developmental Medicine"}],"primaryAppointment":"Clinical Instructor,Pediatrics - Neonatal and Developmental Medicine","imageUrl":"http://stanfordhospital.org/profiles/viewImage?facultyId=3914&type=small&showNoImage","displayName":"Suzanne Mendez","firstName":"Suzanne","href":"http://stanfordhospital.org/profiles/Suzanne_Mendez","researchInterest":""},{"lastName":"Twist","clinicalFocus":[{"focus":"Hematology/Oncology/Stem Cell Transplant,  Pediatric"},{"focus":"Oncology (Cancer), Pediatric"},{"focus":"Pediatric Hematology-Oncology"}],"appointments":[{"appointment":"Associate Professor - Med Center Line,Pediatrics - Hematology & Oncology"}],"primaryAppointment":"Associate Professor - Med Center Line,Pediatrics - Hematology & Oncology","imageUrl":"http://stanfordhospital.org/profiles/viewImage?facultyId=4366&type=small&showNoImage","displayName":"Clare J. Twist","firstName":"Clare","href":"http://stanfordhospital.org/profiles/Clare_Twist","researchInterest":"My primary research interest is in the study and treatment of neuroblastoma. My clinical interests also include Wilms tumor, hepatoblastoma, post-transplant lymphoproliferative disorders, phase I therapies for hematologic malignancies, as well as  palliative and end of life care."},{"lastName":"Schwartz","clinicalFocus":[{"focus":"Pathology"},{"focus":"Anatomic Pathology"}],"appointments":[{"appointment":"Assistant Professor - Med Center Line,Pathology"}],"primaryAppointment":"Assistant Professor - Med Center Line,Pathology","imageUrl":"http://stanfordhospital.org/profiles/viewImage?facultyId=6794&type=small&showNoImage","displayName":"Erich Schwartz","firstName":"Erich","href":"http://stanfordhospital.org/profiles/Erich_Schwartz","researchInterest":""},{"lastName":"Seita","clinicalFocus":[],"appointments":[{"appointment":"Instructor,Stem Cell - Stem Cell Biology and Regenerative Medicine Institute"}],"primaryAppointment":"Instructor,Stem Cell - Stem Cell Biology and Regenerative Medicine Institute","imageUrl":"http://stanfordhospital.org/profiles/viewImage?facultyId=10040&type=small&showNoImage","displayName":"Jun Seita","firstName":"Jun","href":"http://med.stanford.edu/profiles/stanfordhospital/researcher/Jun_Seita","researchInterest":""},{"lastName":"Levy","clinicalFocus":[{"focus":"Lymphoma "},{"focus":"Non-Hodgkin's Lymphoma"},{"focus":"Non-Hodgkin's Lymphoma - Medical Oncology"},{"focus":"Burkitt's Lymphoma"},{"focus":"Burkitt's Lymphoma - Medical Oncology"},{"focus":"Hodgkin's Disease"},{"focus":"Hodgkin's Disease - Medical Oncology"},{"focus":"Burkitt's Lymphoma - Hematology"},{"focus":"Hodgkin's Disease - Hematology"},{"focus":"Oncology (Cancer)"},{"focus":"Non-Hodgkin's Lymphoma - Hematology"},{"focus":"Medical Oncology"}],"appointments":[{"appointment":"Professor,Medicine - Oncology"},{"appointment":"Member,Bio-X"},{"appointment":"Member,Stanford Cancer Institute"}],"primaryAppointment":"Professor,Medicine - Oncology","imageUrl":"http://stanfordhospital.org/profiles/viewImage?facultyId=4608&type=small&showNoImage","displayName":"Ronald Levy, MD","firstName":"Ronald","href":"http://stanfordhospital.org/profiles/Ronald_Levy","researchInterest":"Clinical Interests: lymphoma. Research Interests: Immunology and molecular biology of lymphoid malignancy; molecular vaccines for cancer."},{"lastName":"Price","clinicalFocus":[{"focus":"Hematology"}],"appointments":[],"imageUrl":"http://stanfordhospital.org/profiles/viewImage?facultyId=7226&type=small&showNoImage","displayName":"Elizabeth Price","firstName":"Elizabeth","href":"http://stanfordhospital.org/profiles/Elizabeth_Price","researchInterest":""},{"lastName":"Cornbleet","clinicalFocus":[],"appointments":[{"appointment":"Emeritus Faculty-Med Ctr Line,Pathology"}],"primaryAppointment":"Emeritus Faculty-Med Ctr Line,Pathology","imageUrl":"http://stanfordhospital.org/profiles/viewImage?facultyId=4109&type=small&showNoImage","displayName":"Phyllis Cornbleet","firstName":"Phyllis","href":"http://med.stanford.edu/profiles/stanfordhospital/researcher/Phyllis_Cornbleet","researchInterest":"As medical director of the Hematology Laboratory, my main focus is service work, including laboratory administration, bone marrow pathology, and flow cytometry interpretation. Publications arise primarily from development or evaluation of laboratory methods or collections of unusual patient cases."},{"lastName":"Link","clinicalFocus":[{"focus":"Hematology/Oncology/Stem Cell Transplant,  Pediatric"},{"focus":"Pediatric Hematology-Oncology"}],"appointments":[{"appointment":"Professor,Pediatrics - Hematology & Oncology"},{"appointment":"Member,Child Health Research Institute"},{"appointment":"Member,Stanford Cancer Institute"}],"primaryAppointment":"Professor,Pediatrics - Hematology & Oncology","imageUrl":"http://stanfordhospital.org/profiles/viewImage?facultyId=4631&type=small&showNoImage","displayName":"Michael Link","firstName":"Michael","href":"http://stanfordhospital.org/profiles/Michael_Link","researchInterest":"Hematology/Oncology, treatment of sarcomas of bone and soft tissue, biology of acute lymphoblastic leukemias, treatment of non-Hodgkin's lymphoma and Hodgkin's disease."},{"lastName":"Cleary","clinicalFocus":[],"appointments":[{"appointment":"Professor,Pathology"},{"appointment":"Member,Child Health Research Institute"},{"appointment":"Member,Stanford Cancer Institute"},{"appointment":"Professor,Pediatrics"}],"primaryAppointment":"Professor,Pathology","imageUrl":"http://stanfordhospital.org/profiles/viewImage?facultyId=4506&type=small&showNoImage","displayName":"Michael Cleary","firstName":"Michael","href":"http://med.stanford.edu/profiles/stanfordhospital/researcher/Michael_Cleary","researchInterest":"The role of oncoproteins in cancer and development; molecular and cellular biology of hematologic malignancies; targeted molecular therapies of cancer."},{"lastName":"Chen","clinicalFocus":[],"appointments":[{"appointment":"MD Student, School of Medicine"},{"appointment":"Ph.D., Stem Cell"}],"primaryAppointment":"MD Student, School of Medicine","imageUrl":"http://stanfordhospital.org/profiles/viewImage?facultyId=18041&type=small&showNoImage","displayName":"James Y. Chen","firstName":"James","href":"http://med.stanford.edu/profiles/stanfordhospital/researcher/James_Chen","researchInterest":""},{"lastName":"Coutre","clinicalFocus":[{"focus":"Hematology"},{"focus":"Leukemia"},{"focus":"Chronic Lymphocytic Leukemia"},{"focus":"Multiple Myeloma"},{"focus":"Acute Myelogenous Leukemia"},{"focus":"Acute Lymphoblastic Leukemia"},{"focus":"Chronic Myeloid Leukemias"},{"focus":"Plasmacytoma"},{"focus":"Idiopathic Hypereosinophillic Syndrome"}],"appointments":[{"appointment":"Professor - Med Center Line,Medicine - Hematology"},{"appointment":"Member,Stanford Cancer Institute"}],"primaryAppointment":"Professor - Med Center Line,Medicine - Hematology","imageUrl":"http://stanfordhospital.org/profiles/viewImage?facultyId=4695&type=small&showNoImage","displayName":"Steven Coutre","firstName":"Steven","href":"http://stanfordhospital.org/profiles/Steven_Coutre","researchInterest":"My research integrates clinical care of patients with novel treatments for a variety of hematologic disorders.  I see patients with a wide range of problems with a particular focus on chronic lymphocytic leukemia and multiple myeloma.  I provide comprehensive consultative services as well as treatment for both the acute and chronic leukemias as well as non-malignant conditions such as clotting disorders and thrombocytopenia."},{"lastName":"Clarke","clinicalFocus":[{"focus":"Colorectal Cancer"},{"focus":"Oncology (Cancer)"},{"focus":"Medical Oncology"}],"appointments":[{"appointment":"Professor,Medicine - Oncology"},{"appointment":"Member,Bio-X"},{"appointment":"Member,Stanford Cancer Institute"}],"primaryAppointment":"Professor,Medicine - Oncology","imageUrl":"http://stanfordhospital.org/profiles/viewImage?facultyId=7126&type=small&showNoImage","displayName":"Michael F. Clarke, M.D.","firstName":"Michael","href":"http://stanfordhospital.org/profiles/Michael_Clarke","researchInterest":"Dr. Michael F. Clarke is the Associate Director of the Stanford Institute for Stem Cell and Regenerative Medicine.  In addition to his clinical duties in the division of Oncology, Dr. Clarke maintains a laboratory  focused on two areas of research: i) the control of self-renewal of normal stem cells and their malignant counterparts; and ii) the identification and characterization of cancer stem cells. A central issue in stem cell biology is to understand the mechanisms that regulate self-renewa"},{"lastName":"Kohrt","clinicalFocus":[{"focus":"Oncology"}],"appointments":[{"appointment":"Assistant Professor - Med Center Line,Medicine - Oncology"}],"primaryAppointment":"Assistant Professor - Med Center Line,Medicine - Oncology","imageUrl":"http://stanfordhospital.org/profiles/viewImage?facultyId=10873&type=small&showNoImage","displayName":"Holbrook Kohrt","firstName":"Holbrook","href":"http://stanfordhospital.org/profiles/Holbrook_Kohrt","researchInterest":"My research is focused on developing novel therapeutic strategies to enhance anti-tumor immunity. Investigation of preclinical models of bone marrow transplantation and immunomodulatory antibody therapy provides the platform for translation to early phase clinical trials."},{"lastName":"Higgins","clinicalFocus":[{"focus":"Pathology and Laboratory Medicine"},{"focus":"Anatomic/Clinical Pathology"}],"appointments":[{"appointment":"Associate Professor - Med Center Line,Pathology"},{"appointment":"Member,Bio-X"}],"primaryAppointment":"Associate Professor - Med Center Line,Pathology","imageUrl":"http://stanfordhospital.org/profiles/viewImage?facultyId=4038&type=small&showNoImage","displayName":"John Higgins","firstName":"John","href":"http://stanfordhospital.org/profiles/John_Higgins","researchInterest":"I work as a diagnostic surgical pathologist doing translational research in renal neoplasia and medical renal disease and neoplastic and medical liver disease. Subspecialty areas of clinical interest include diagnostic immunohistochemistry, renal, hepatic and transplant pathology."}]}